Benitec Biopharma increases authorized common shares from 40M to 160M

Benitec Biopharma Inc.

Stockholders approved amendment at Dec 7, 2022 annual meeting; effective Dec 9, 2022.
Authorized common shares increased from 40,000,000 to 160,000,000.
Certificate of Amendment filed with Delaware Secretary of State on Dec 9, 2022.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Benitec Biopharma Inc.: Increased authorized shares of common stock from 40,000,000 to 160,000,000 (effective 2022-12-09).

Change: charter amendment
Effective: 2022-12-09

Exact text from the filing

the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock of the Company from 40,000,000 to 160,000,000.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Benitec Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-302288

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.